Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -37.85%1.22B | -39.93%4.1B | -51.47%1.96B | -23.68%6.83B | -13.66%4.05B | -22.19%8.95B | -8.25%4.69B | 49.81%11.5B | 60.05%5.11B | 21.37%7.68B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -34.01%-303.06M | 28.34%-328.43M | 2.07%-226.15M | -91.09%-458.33M | -96.00%-230.93M | -30.76%-239.85M | -45.86%-117.82M | -126.65%-183.44M | -226.26%-80.78M | -34.94%-80.93M |
| Dividend (income)- adjustment | -0.27%-1.49M | -23.91%-2.83M | -19.92%-1.49M | -13.24%-2.28M | -19.00%-1.24M | 3.31%-2.02M | 6.46%-1.04M | -13.62%-2.09M | -9.22%-1.11M | -1.10%-1.84M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---59.63M | ---- | ---- | ---- | ---4.75M | 17.14%-30.77M |
| Attributable subsidiary (profit) loss | 384.01%2.66M | -236.54%-1.8M | -147.40%-938K | 332.22%1.32M | 1,851.33%1.98M | 91.16%-568K | 95.87%-113K | -219.50%-6.42M | -430.68%-2.73M | -266.39%-2.01M |
| Impairment and provisions: | 2,966.04%40.81M | 60.30%118.66M | -95.39%1.33M | 236.97%74.02M | 358.24%28.85M | 172.75%21.97M | 129.36%6.3M | 19.62%8.05M | -20.96%2.75M | -50.11%6.73M |
| -Impairmen of inventory (reversal) | 245.92%44.99M | -59.13%11.14M | 81.32%13.01M | 93.73%27.26M | 139.10%7.17M | 359.75%14.07M | 62.43%3M | 126.24%3.06M | 14.72%1.85M | -42.47%1.35M |
| -Impairment of trade receivables (reversal) | 64.18%-4.18M | -83.77%7.59M | -153.86%-11.68M | 492.34%46.76M | 557.71%21.68M | 58.10%7.89M | 267.04%3.3M | -7.19%4.99M | -51.80%898K | -15.95%5.38M |
| -Impairment of goodwill | ---- | --99.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | 352.48%23.35M | 78.87%-5.32M | 51.30%-9.25M | -348.88%-25.16M | -3,845.17%-18.99M | 149.03%10.11M | 109.04%507K | ---20.62M | 68.90%-5.61M | ---- |
| -Other fair value changes | 352.48%23.35M | 78.87%-5.32M | 51.30%-9.25M | -348.88%-25.16M | -3,845.17%-18.99M | 149.03%10.11M | 109.04%507K | ---20.62M | 68.90%-5.61M | ---- |
| Asset sale loss (gain): | -244.14%-35.1M | -121.90%-20.42M | 343.58%24.35M | 173.92%93.24M | -88.36%5.49M | -2,265.07%-126.13M | 659.36%47.16M | 58.65%-5.33M | -11.77%-8.43M | -141.77%-12.9M |
| -Loss (gain) from sale of subsidiary company | -78.07%3.78M | --17.24M | --17.24M | ---- | ---- | -14.55%-1.06M | --533K | ---928K | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -616.34%-38.72M | -71.43%27.12M | 36.60%7.5M | 196.36%94.91M | -88.23%5.49M | -1,362.90%-98.5M | 653.04%46.63M | 47.80%-6.73M | -11.77%-8.43M | -141.77%-12.9M |
| -Loss (gain) from selling other assets | 58.88%-162K | -3,767.28%-64.78M | ---394K | 93.70%-1.68M | ---- | -1,241.28%-26.57M | ---- | --2.33M | ---- | ---- |
| Depreciation and amortization: | -6.52%1.57B | 29.71%2.88B | 62.77%1.67B | -22.19%2.22B | -28.47%1.03B | 20.12%2.85B | 30.14%1.44B | 22.38%2.37B | 19.77%1.11B | 11.58%1.94B |
| -Amortization of intangible assets | -1.77%254.84M | 0.68%517.92M | 0.76%259.43M | -2.77%514.44M | -2.07%257.47M | 21.91%529.08M | 34.17%262.91M | 17.35%434M | 9.71%195.95M | 8.13%369.83M |
| Financial expense | -13.99%681.41M | 4.34%1.57B | 10.35%792.25M | 23.70%1.51B | 28.15%717.97M | 8.80%1.22B | -6.05%560.24M | -11.09%1.12B | -2.28%596.34M | -9.40%1.26B |
| Special items | ---- | ---- | ---2.76M | -528.55%-58.08M | ---- | -94.42%-9.24M | ---9.24M | 47.46%-4.75M | ---- | -156.45%-9.05M |
| Operating profit before the change of operating capital | -24.22%3.2B | -18.34%8.31B | -23.61%4.22B | -19.67%10.18B | -16.52%5.52B | -14.26%12.67B | -1.46%6.61B | 37.55%14.78B | 43.23%6.71B | 14.29%10.75B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 172.94%1.47B | -91.07%-2.09B | -955.42%-2.01B | 73.07%-1.09B | 94.04%-190.39M | -327.46%-4.07B | -781.68%-3.19B | -194.85%-951.32M | -3.92%468.69M | -19.55%1B |
| Accounts receivable (increase)decrease | -96.80%5.33M | 78.17%-518.59M | 121.79%166.45M | -7,400.81%-2.38B | -929.20%-764.04M | -88.70%32.54M | 125.91%92.14M | 508.55%287.98M | -1,673.08%-355.66M | 138.28%47.32M |
| Accounts payable increase (decrease) | 88.65%3.92B | -36.71%1.99B | 57.57%2.08B | 61.39%3.14B | 41,926.60%1.32B | 342.27%1.94B | 99.46%-3.15M | -315.97%-802.12M | -1,231.27%-583.57M | 105.26%371.4M |
| prepayments (increase)decrease | -299.17%-2.19B | -87.81%-3.09B | 59.40%-548.21M | -299.76%-1.65B | -179.43%-1.35B | 1,710.87%824.74M | 22.99%1.7B | 103.83%45.54M | 224.02%1.38B | 6.25%-1.19B |
| Special items for working capital changes | 72.68%-63.11M | 73.01%58.58M | -501.90%-231.03M | -59.77%33.86M | 57.74%-38.38M | 275.72%84.16M | 44.30%-90.82M | -154.54%-47.9M | -65.47%-163.06M | -47.48%87.82M |
| Cash from business operations | 72.50%6.34B | -43.49%4.65B | -18.30%3.67B | -28.36%8.23B | -12.11%4.5B | -13.68%11.49B | -31.42%5.12B | 20.29%13.31B | 34.82%7.46B | 15.21%11.07B |
| Other taxs | 48.11%-387.96M | 32.88%-1.21B | 27.36%-747.71M | 33.27%-1.81B | 29.64%-1.03B | -10.87%-2.71B | -38.36%-1.46B | -39.99%-2.44B | -34.02%-1.06B | 3.50%-1.74B |
| Net cash from operations | 103.32%5.95B | -46.48%3.44B | -15.62%2.93B | -26.85%6.43B | -5.09%3.47B | -19.20%8.78B | -42.94%3.65B | 16.60%10.87B | 34.96%6.4B | 19.55%9.32B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 34.56%301.85M | -28.92%323.06M | -2.86%224.32M | 89.50%454.53M | 96.00%230.93M | 30.76%239.85M | 45.86%117.82M | 126.65%183.44M | 226.26%80.78M | 34.94%80.93M |
| Dividend received - investment | 0.27%1.49M | 23.91%2.83M | 19.92%1.49M | 13.24%2.28M | 19.00%1.24M | -3.31%2.02M | -6.46%1.04M | 13.62%2.09M | --1.11M | 1.10%1.84M |
| Sale of fixed assets | -38.81%405.16M | -16.72%1.46B | -19.81%662.16M | 26.74%1.76B | 15.07%825.8M | 37.93%1.39B | 50.38%717.67M | 27.45%1.01B | 45.03%477.25M | -9.88%788.74M |
| Purchase of fixed assets | -29.62%-1.6B | 26.65%-2.1B | 23.59%-1.24B | 9.35%-2.86B | -12.93%-1.62B | 29.89%-3.16B | 26.28%-1.44B | -39.43%-4.51B | -65.91%-1.95B | -21.17%-3.23B |
| Selling intangible assets | --166K | ---- | ---- | ---- | ---- | --32.93M | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | 32.06%-81.85M | -552.64%-188.23M | -170.56%-120.47M | 95.83%-28.84M | 77.75%-44.53M | -20.98%-691.67M | 36.77%-200.07M | -1,009.03%-571.74M | -1,363.54%-316.42M | 47.98%-51.55M |
| Sale of subsidiaries | 1,319.93%15.32M | --10.78M | --1.08M | ---- | ---- | -80.51%3.4M | --2.72M | 1,407.08%17.47M | ---- | -71.03%1.16M |
| Acquisition of subsidiaries | -270,978.95%-51.47M | 57.84%-33.99M | 100.24%19K | -209.04%-80.62M | -118.15%-7.97M | 101.37%73.93M | 116.29%43.93M | -506.19%-5.41B | -14,832.61%-269.75M | -1,505.67%-892.3M |
| Recovery of cash from investments | --73.15M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --843.55M |
| Cash on investment | -99.58%153K | 335.24%1.14B | -64.29%36.36M | 117.65%262.51M | 222.33%101.82M | -984.26%-1.49B | -185.90%-83.23M | 82.91%-137.15M | 97.41%-29.11M | 39.63%-802.58M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -34.54%18.54M | -23.71%28.33M |
| Net cash from investment operations | -117.17%-940.99M | 224.65%619.53M | 15.59%-433.29M | 86.19%-497.02M | 38.54%-513.34M | 61.77%-3.6B | 57.91%-835.23M | -191.16%-9.42B | -81.48%-1.98B | -3.03%-3.23B |
| Net cash before financing | 100.91%5.01B | -31.54%4.06B | -15.62%2.49B | 14.35%5.93B | 4.82%2.95B | 256.19%5.19B | -36.22%2.82B | -76.10%1.46B | 21.02%4.42B | 30.68%6.09B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -14.62%44.28B | -12.99%100.55B | -1.72%51.86B | 8.22%115.56B | 3.39%52.77B | -5.63%106.78B | -14.51%51.04B | 2.18%113.16B | 27.17%59.7B | 21.98%110.75B |
| Refund | 7.65%-47.74B | 8.33%-100.09B | -7.46%-51.69B | -3.14%-109.2B | 9.98%-48.11B | 5.50%-105.87B | 11.93%-53.44B | 0.24%-112.04B | -27.21%-60.68B | -21.32%-112.31B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -39.54%2.5B | ---- | --4.13B |
| Issuance of bonds | ---- | --5.23B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | -61.02%-1.05B | 1.54%-1.22B | -19.15%-652.77M | -44.06%-1.24B | -42.53%-547.84M | -13.52%-859.63M | 6.43%-384.36M | 14.12%-757.25M | 5.71%-410.78M | 18.18%-881.75M |
| Dividends paid - financing | 82.02%-2.88M | 27.08%-1.75B | -1,205.47%-15.99M | -30.24%-2.4B | 66.31%-1.23M | -51.80%-1.84B | 92.18%-3.64M | -22.67%-1.22B | -294.23%-46.48M | 16.20%-990.56M |
| Absorb investment income | ---- | ---- | ---- | --778K | --778K | ---- | ---- | ---- | ---- | 66.67%25M |
| Issuance expenses and redemption of securities expenses | -8,425.70%-2.82B | -18.04%-2.21B | 98.05%-33.12M | -361.80%-1.87B | -2,584.39%-1.7B | -437.62%-405.37M | 16.19%-63.19M | 98.06%-75.4M | 98.06%-75.4M | ---3.88B |
| Pledged bank deposit (increase) decrease | -1,803.33%-2.8B | 81.32%-385.15M | 141.13%164.25M | -103.75%-2.06B | -2.93%-399.36M | -260.96%-1.01B | -154.41%-388M | 841.16%628.77M | 2,706.08%713.08M | -214.84%-84.84M |
| Other items of the financing business | ---- | -304.65%-54.67M | -262.70%-39.25M | 104.99%26.71M | -97.91%24.12M | -220.81%-535.78M | 209.94%1.15B | -29.22%-167.01M | -210.74%-1.05B | -662.66%-129.25M |
| Net cash from financing operations | -1,049.16%-10.83B | 50.02%-1B | -155.79%-942.45M | 55.79%-2B | 169.85%1.69B | -448.06%-4.53B | -13.27%-2.42B | 132.81%1.3B | -38.96%-2.14B | 15.87%-3.96B |
| Effect of rate | 64.82%-5.41M | 219.10%16.91M | -150.21%-15.39M | -92.51%5.3M | -58.02%30.66M | 525.38%70.75M | 731.90%73.03M | 4.64%-16.63M | -206.73%-11.56M | -281.55%-17.44M |
| Net Cash | -475.71%-5.82B | -22.13%3.06B | -66.62%1.55B | 496.69%3.93B | 1,062.36%4.64B | -76.12%658.24M | -82.50%399.44M | 29.61%2.76B | 7.98%2.28B | 4,262.03%2.13B |
| Begining period cash | 19.70%18.69B | 33.68%15.61B | 33.68%15.61B | 6.66%11.68B | 6.66%11.68B | 33.37%10.95B | 33.37%10.95B | 34.57%8.21B | 34.57%8.21B | -0.68%6.1B |
| Cash at the end | -25.00%12.86B | 19.70%18.69B | 4.85%17.15B | 33.68%15.61B | 43.16%16.35B | 6.66%11.68B | 8.98%11.42B | 33.37%10.95B | 27.42%10.48B | 34.57%8.21B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.